YOLFTbeta
68

BiOptic Inc.

6850 · TWO · Healthcare / Biotechnology

28.60TWD+0.45 (+1.60%)

Price History

Full chart

Market Stats

Previous Close28.15
Open28.60
Day Range28.60 – 28.60
52-Week Range30.90 – 47.72
Volume20
Market Cap1.03B
P/E (TTM)119.23
Forward P/E0.00
EPS0.26
Dividend Yield1.61%
50-Day Avg32.95
200-Day Avg37.56

About

BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • HeadquartersNo. 108-3, Minquan Road, New Taipei City, Taiwan, Taiwan
  • Websitehttps://www.bioptic.com.tw

Financials

Income Statement

Currency: TWD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue62.14M91.96M123.63M179.28M231.40M228.27M202.69M
Growth (%)-+47.98%+34.43%+45.02%+29.07%-1.35%-11.21%
Cost of Revenue35.43M41.33M44.45M68.91M78.76M75.52M77.41M
Gross Profit26.71M50.63M79.17M110.38M152.65M152.75M125.28M
Gross Margin42.99%55.06%64.04%61.57%65.97%66.91%61.81%
Operating Expense42.58M47.17M52.20M66.22M87.64M108.69M106.11M
Operating Income-15.87M3.46M26.97M44.16M65.00M44.05M19.17M
Operating Margin-25.53%3.76%21.82%24.63%28.09%19.30%9.46%
EBITDA-11.12M7.13M32.09M57.38M88.91M65.04M46.62M
EBITDA Margin-17.89%7.75%25.96%32.00%38.42%28.49%23.00%
Net Income-14.73M2.19M25.93M46.25M61.27M37.75M22.73M
Net Income Margin-23.70%2.38%20.98%25.80%26.48%16.54%11.21%
R&D14.01M14.79M20.49M26.74M35.45M40.49M34.75M
R&D as % of Total Revenue22.54%16.08%16.57%14.92%15.32%17.74%17.15%
Interest Expense517.00K1.24M1.02M609.00K286.00K1.34M1.97M
Interest Expense % of Total Revenue0.83%1.35%0.83%0.34%0.12%0.59%0.97%

Balance Sheet

Currency: TWD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets--290.86M419.48M521.44M613.77M596.41M-
Total Liabilities--109.66M44.69M94.08M170.56M134.66M-
Total Equity--180.09M368.09M418.50M431.77M449.72M-
Cash-32.95M62.53M150.03M207.22M80.61M98.13M-
Total Debt--86.08M5.86M14.34M93.20M86.17M-
Net Debt--32.95M23.55M-144.17M-192.88M12.59M-11.95M-

Cash Flow

Currency: TWD2020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow14.60M32.43M69.47M-12.75M31.05M
Investing Cash Flow952.00K-7.72M2.24M-159.04M-2.15M
Financing Cash Flow-1.85M62.72M-14.75M45.94M-12.53M
Capital Expenditure1.03M7.68M6.88M114.12M6.79M
Free Cash Flow11.88M24.74M62.60M-126.87M24.27M
Dividends Paid--11.00M24.20M5.32M
FCF to OCF81.40%76.30%90.10%995.34%78.15%
Dividend Paid to FCF--17.57%-19.08%21.94%

Key Statistics & Ratios

Market Cap1.03B
Enterprise Value944.55M
Trailing P/E119.23
Forward P/E0.00
Price / Sales4.54
Price / Book2.40
EPS0.26
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding33.09M
Shares Float0
Dividend Yield1.61%
Dividend Rate0.50
Payout Ratio115.38%

Dividends

20261×
0.50Aug 25, 2026
20251×
0.30Aug 20, 2025
20241×
0.18Aug 21, 2024
20231×
0.80Aug 24, 2023
20221×
0.36Aug 25, 2022

Stock Splits

  • Aug 20, 20251100:1000
  • Aug 21, 20241133825:1000000
  • Aug 24, 20231100:1000
  • Aug 25, 20221100:1000